Illustrative image – not actual.Jubilant HollisterStier, a subsidiary of Jubilant Life Sciences, has signed an agreement with a US based pharma company to manufacture an over the counter (OTC) women health and personal care product at its Montreal facility in North America.
The contract has a total value of over $70 million (approx Rs 332.5 crore) for a period of over four years with a possibility of extension for another two years for a higher quantity. The production of the product under this agreement has already commenced in early September 2011 at Jubilant HollisterStier manufacturing facility in Montreal.
Jubilant’s facility in Montreal manufactures global quality OCL (ointment, creams liquid) products as well as sterile liquid and lyophilized products.
